These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11478935)

  • 1. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.
    He Y; Appel S; Le W
    Brain Res; 2001 Aug; 909(1-2):187-93. PubMed ID: 11478935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.
    Silva C; Fuxe K; Chadi G
    J Neural Transm Suppl; 2009; (73):185-202. PubMed ID: 20411778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Hydroxydopamine as a tool to understand adaptive immune system-induced dopamine neurodegeneration in Parkinson's disease.
    Theodore S; Maragos W
    Immunopharmacol Immunotoxicol; 2015; 37(4):393-9. PubMed ID: 26211726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.
    Gao JP; Sun S; Li WW; Chen YP; Cai DF
    Neurosci Bull; 2008 Jun; 24(3):133-42. PubMed ID: 18500385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo.
    Huang CF; Li G; Ma R; Sun SG; Chen JG
    Neurosci Bull; 2008 Apr; 24(2):66-72. PubMed ID: 18369384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine.
    Rodrigues RW; Gomide VC; Chadi G
    Int J Neurosci; 2001 Jul; 109(1-2):91-126. PubMed ID: 11699344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline enhances MPTP toxicity to dopaminergic neurons.
    Yang L; Sugama S; Chirichigno JW; Gregorio J; Lorenzl S; Shin DH; Browne SE; Shimizu Y; Joh TH; Beal MF; Albers DS
    J Neurosci Res; 2003 Oct; 74(2):278-85. PubMed ID: 14515357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    McCoy MK; Martinez TN; Ruhn KA; Szymkowski DE; Smith CG; Botterman BR; Tansey KE; Tansey MG
    J Neurosci; 2006 Sep; 26(37):9365-75. PubMed ID: 16971520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions.
    Kumar V; Singh BK; Chauhan AK; Singh D; Patel DK; Singh C
    Mol Neurobiol; 2016 Jul; 53(5):2761-2777. PubMed ID: 25764516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat.
    Martí MJ; Saura J; Burke RE; Jackson-Lewis V; Jiménez A; Bonastre M; Tolosa E
    Brain Res; 2002 Dec; 958(1):185-91. PubMed ID: 12468044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration.
    Hernandes MS; Santos GD; Café-Mendes CC; Lima LS; Scavone C; Munhoz CD; Britto LR
    PLoS One; 2013; 8(9):e75532. PubMed ID: 24086556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
    Gomide V; Bibancos T; Chadi G
    Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration.
    Purisai MG; McCormack AL; Cumine S; Li J; Isla MZ; Di Monte DA
    Neurobiol Dis; 2007 Feb; 25(2):392-400. PubMed ID: 17166727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.
    Cicchetti F; Brownell AL; Williams K; Chen YI; Livni E; Isacson O
    Eur J Neurosci; 2002 Mar; 15(6):991-8. PubMed ID: 11918659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease.
    Zhang S; Wang XJ; Tian LP; Pan J; Lu GQ; Zhang YJ; Ding JQ; Chen SD
    J Neuroinflammation; 2011 Nov; 8():154. PubMed ID: 22053982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
    Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
    J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.